These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4259647)

  • 21. [Decreasing blood lipids for prevention of coronary heart disease--discussion of the "permissive LDL level". Diagnostic imaging facilitates therapeutic decision].
    MMW Fortschr Med; 2001 Mar; 143(13):48-9. PubMed ID: 11332020
    [No Abstract]   [Full Text] [Related]  

  • 22. Dietary and other factors which influence serum lipids.
    Hodges RE
    J Am Diet Assoc; 1968 Mar; 52(3):198-201. PubMed ID: 5640961
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical implications of clinical studies: can we compare different subgroups defined a posteriori?
    Vohnout B
    Eur Heart J; 2001 May; 22(9):798. PubMed ID: 11350113
    [No Abstract]   [Full Text] [Related]  

  • 24. Regression of coronary artery disease as a result of intensive lipid-lowering therapy.
    N Engl J Med; 1991 Apr; 324(16):1133-5. PubMed ID: 2008188
    [No Abstract]   [Full Text] [Related]  

  • 25. Lipids and coronary restenosis:an elusive link.
    de Feyter PJ
    Eur Heart J; 1999 Oct; 20(19):1371-4. PubMed ID: 10487795
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood coagulability in coronary sclerosis--results of thrombelastography].
    Toyama S; Suzuki K
    Saishin Igaku; 1970 Apr; 25(4):951-6. PubMed ID: 5420849
    [No Abstract]   [Full Text] [Related]  

  • 27. New trends in lipid management: eight cases to consider.
    Smith DA
    Mt Sinai J Med; 2005 Mar; 72(2):90-9. PubMed ID: 15770338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol and coronary heart disease: screening and treatment.
    Turner-Boutle M
    Nurs Times; 1998 Apr 15-21; 94(15):46-7. PubMed ID: 9615661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Action of ethyl chlorophenoxyisobutyrate (CPIB) on blood lipids].
    Giannini SD; da Silva WN; Luthold WW; Coelho LT; Bitelli T
    Rev Bras Med; 1965 Nov; 22(11):702-7. PubMed ID: 5892979
    [No Abstract]   [Full Text] [Related]  

  • 30. Statins in the prevention of coronary heart disease.
    Williamson DR; Pharand C
    Pharmacotherapy; 1998; 18(2):242-54. PubMed ID: 9545143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Postprandial lipemia and blood platelet adhesion ability in coronary sclerosis].
    Imamura H; Fukuzaki H; Takamiya T; Matsuo T
    Naika; 1972; 29(1):123-8. PubMed ID: 5011294
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prolonged use of atromid in patients with coronary arteriosclerosis].
    Zadionchenko VS
    Kardiologiia; 1967 Oct; 7(10):32-5. PubMed ID: 5607197
    [No Abstract]   [Full Text] [Related]  

  • 33. [Better clinical outcome in coronary disease patients with lower level of low-density lipoprotein cholesterol].
    Zhao SP
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):865-7. PubMed ID: 16029518
    [No Abstract]   [Full Text] [Related]  

  • 34. Lipids and coronary artery disease.
    Corman A; Brest AN
    Geriatrics; 1968 Mar; 23(3):157-65. PubMed ID: 5639685
    [No Abstract]   [Full Text] [Related]  

  • 35. [Is regression of coronary sclerosis possible?].
    Krayenbühl HP
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1348-53. PubMed ID: 8272700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is there a reason to take the cholesterol campaign seriously?].
    Ravnskov U
    Lakartidningen; 2009 Jan 7-13; 106(1-2):47-8; discussion 48. PubMed ID: 19235322
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative study of blood lipids in coronary sclerosis and cerebrosclerosis].
    Keller L; Fischer J; Farádi A
    Orv Hetil; 1974 Jun; 115(23):1323-7. PubMed ID: 4840692
    [No Abstract]   [Full Text] [Related]  

  • 38. [Regression of coronary sclerosis].
    Trenkwalder P; Lydtin H
    Dtsch Med Wochenschr; 1991 Mar; 116(11):438-9. PubMed ID: 2001659
    [No Abstract]   [Full Text] [Related]  

  • 39. Reduction of coronary events by pravastatin--is lowering low-density lipoprotein cholesterol the answer?
    Halle M; Bery A; Keul J
    Am J Cardiol; 1997 Sep; 80(5):683. PubMed ID: 9295011
    [No Abstract]   [Full Text] [Related]  

  • 40. [Influence of beta-benzabutyramide on the blood lipids and on the thrombodensitogram].
    Ferri F; Regazzini A; Pedini G
    G Gerontol; 1970 Mar; 18(3):203-18. PubMed ID: 5473222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.